Financials
- Market Capitalization 1.75 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-63.19
市销率
15.2
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.50% | -3.15% | +11.55% | -28.09% | 1.81 B USD | ||
| 2084 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.76 USD | +0.55% | -3.26% | +20.49% | -7.00% | 1.79 B USD | ||
| 2095 | FTRE Fortrea Holdings Inc. - Common Stock | 18.36 USD | +3.61% | -0.92% | -4.57% | +77.56% | 1.75 B USD | ||
| 2106 | GHRS GH Research PLC - Ordinary Shares | 28.09 USD | +2.67% | -3.17% | -0.28% | +98.38% | 1.74 B USD |